Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial

INTRODUCTION: Organ preservation is associated with superior functional outcome and quality of life (QoL) compared with total mesorectal excision (TME) for rectal cancer. Only 10% of patients are eligible for organ preservation following short-course radiotherapy (SCRT, 25 Gy in five fractions) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Verweij, Maaike E, Tanaka, Max D, Kensen, Chavelli M, van der Heide, Uulke A, Marijnen, Corrie A M, Janssen, Tomas, Vijlbrief, Tineke, van Grevenstein, Wilhelmina M U, Moons, Leon M G, Koopman, Miriam, Lacle, Miangela M, Braat, Manon N G J A, Chalabi, Myriam, Maas, Monique, Huibregtse, Inge L, Snaebjornsson, Petur, Grotenhuis, Brechtje A, Fijneman, Remond, Consten, Esther, Pronk, Apollo, Smits, Anke B, Heikens, Joost T, Eijkelenkamp, Hidde, Elias, Sjoerd G, Verkooijen, Helena M, Schoenmakers, Maartje M C, Meijer, Gert J, Intven, Martijn, Peters, Femke P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277084/
https://www.ncbi.nlm.nih.gov/pubmed/37321815
http://dx.doi.org/10.1136/bmjopen-2022-065010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277084/
https://www.ncbi.nlm.nih.gov/pubmed/37321815
http://dx.doi.org/10.1136/bmjopen-2022-065010

Ejemplares similares